Related Experiment Video
Updated: Sep 3, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Origin and Therapies of Osteosarcoma
Brice Moukengue1, Morgane Lallier1, Louise Marchandet1
1Nantes Université, INSERM UMR1307, CNRS UMR6075, Université d'Angers, CRCI2NA, Team 9, CHILD, F-44000 Nantes, France.
Osteosarcoma (OS) is a primary bone cancer affecting young people, with survival rates stagnant for decades. This review covers OS origins, diagnosis, and treatments, highlighting challenges in improving outcomes.
Area of Science:
- Oncology
- Pediatric Oncology
- Orthopedic Oncology
Background:
- Osteosarcoma (OS) is the most common primary bone tumor in children and young adults.
- Current 5-year survival rates are 70%, but drop to 20-30% for metastatic or therapy-resistant cases.
- Stagnant survival rates over 40 years are attributed to limited understanding of OS origins, diagnostic challenges, and lack of targeted therapies.
Purpose of the Study:
- To provide a comprehensive overview of osteosarcoma.
- To discuss the clinical and biological aspects of OS.
- To review the current understanding of OS origin, diagnosis, and therapeutic strategies.
Main Methods:
- Literature review of osteosarcoma.
- Synthesis of clinical and biological data.
- Analysis of diagnostic and therapeutic approaches.
Main Results:
- Osteosarcoma remains a significant challenge in pediatric oncology.
- Diagnosis and treatment of OS are complex due to tumor heterogeneity and resistance.
- Advances in understanding OS biology are crucial for developing targeted therapies.
Conclusions:
- Improved survival for osteosarcoma patients necessitates a deeper understanding of its origins and biology.
- Enhanced diagnostic tools and novel targeted therapies are critical for overcoming treatment resistance and metastasis.
- Multidisciplinary approaches are essential for managing this complex pediatric bone cancer.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Tumor Immunotherapy
Cancers Originate from Somatic Mutations in a Single Cell
Bone Formation by Endochondral Ossification

